Loading...

Expanding Global Supportive Cancer Care Will Unlock Future Opportunities

Published
28 Sep 24
Updated
01 May 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
80.3%
7D
-5.5%

Author's Valuation

US$1445.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 01 May 25

Fair value Increased 74%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Decreased 42%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 15%

Shared on 26 Mar 25

Fair value Decreased 6.48%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 3.48%

Shared on 11 Mar 25

Fair value Decreased 3.36%

AnalystConsensusTarget has decreased revenue growth from 48.3% to 31.3% and decreased shares outstanding growth rate from 0.0% to -0.0%.